In contrast, we found CSF Aβ positive and Aβ PET positive (CSF+/PET+, late amyloidosis stage) individuals showed significant tau increases in all the cortical regions than the control group, and the highest tau elevations were found in the Temporal-metaROI44 composite regions. This evidence concerns the gene MAPT and amyloidosis.